Packer M - Search Results

1

Can we expect vasodilator therapy to prolong life in patients with congestive heart failure?

Packer M, Lee WH, Kessler PD, Gottlieb SS. Packer M, et al. J Cardiovasc Pharmacol. 1987;9 Suppl 2:S73-5. doi: 10.1097/00005344-198700002-00015. J Cardiovasc Pharmacol. 1987. PMID: 2441205

2

Cumulative hemodynamic response to short-term treatment with flosequinan (BTS 49465), a new direct-acting vasodilator drug, in severe chronic congestive heart failure.

Kessler PD, Packer M, Medina N, Yushak M. Kessler PD, et al. Among authors: packer m. J Cardiovasc Pharmacol. 1988 Jul;12(1):6-11. doi: 10.1097/00005344-198807000-00002. J Cardiovasc Pharmacol. 1988. PMID: 2459536

3

The erythrocyte sedimentation rate in congestive heart failure.

Haber HL, Leavy JA, Kessler PD, Kukin ML, Gottlieb SS, Packer M. Haber HL, et al. Among authors: packer m. N Engl J Med. 1991 Feb 7;324(6):353-8. doi: 10.1056/NEJM199102073240601. N Engl J Med. 1991. PMID: 1987458 Free article.

4

Prognostic importance of the serum magnesium concentration in patients with congestive heart failure.

Gottlieb SS, Baruch L, Kukin ML, Bernstein JL, Fisher ML, Packer M. Gottlieb SS, et al. Among authors: packer m. J Am Coll Cardiol. 1990 Oct;16(4):827-31. doi: 10.1016/s0735-1097(10)80329-8. J Am Coll Cardiol. 1990. PMID: 2212365 Free article.

5

Deleterious hemodynamic effects of lidocaine in severe congestive heart failure.

Gottlieb SS, Packer M. Gottlieb SS, et al. Among authors: packer m. Am Heart J. 1989 Sep;118(3):611-2. doi: 10.1016/0002-8703(89)90278-0. Am Heart J. 1989. PMID: 2773776 No abstract available.

6

Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure. Basis of a new physiologic approach to control of arrhythmia.

Packer M, Gottlieb SS, Kessler PD. Packer M, et al. Am J Med. 1986 Apr 25;80(4A):23-9. doi: 10.1016/0002-9343(86)90337-2. Am J Med. 1986. PMID: 2871753 Review.

7

Immediate and long-term pathophysiologic mechanisms underlying the genesis of sudden cardiac death in patients with congestive heart failure.

Packer M, Gottlieb SS, Blum MA. Packer M, et al. Am J Med. 1987 Mar 20;82(3A):4-10. doi: 10.1016/0002-9343(87)90126-4. Am J Med. 1987. PMID: 2882674

8

Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure.

Packer M, Lee WH, Kessler PD, Gottlieb SS, Bernstein JL, Kukin ML. Packer M, et al. Circulation. 1987 May;75(5 Pt 2):IV80-92. Circulation. 1987. PMID: 2882867 Review.

9

Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure.

Lee WH, Packer M. Lee WH, et al. Among authors: packer m. Circulation. 1986 Feb;73(2):257-67. doi: 10.1161/01.cir.73.2.257. Circulation. 1986. PMID: 3002660

10

Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management.

Packer M, Kessler PD, Gottlieb SS. Packer M, et al. Postgrad Med J. 1986;62 Suppl 1:179-82. Postgrad Med J. 1986. PMID: 3022272

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,092 results

Search Page

Filters